Skip to main content
. 2000 Sep 12;97(20):10872–10877. doi: 10.1073/pnas.190210897

Figure 3.

Figure 3

BAX mutations and cancer patient survival. TGFβRII mutations are also shown for comparative purposes. No correlation was found between BAX mutations and other clinical or histopathological parameters, including the age, gender, differentiation degree, anatomical localization, or invasiveness of the tumors. The presence of BAX mutations thus appears to be an independent indicator of poor prognosis.